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Abstract 
 
 
TNF-α Production Induced by Peptidoglycan-Polysaccharide in Early Pregnant 
Ewes 
 
 
Gabrielle Marie Rogers 
 
 
Peptidoglycan-polysaccharide (PG-PS), cell wall component of gram-positive bacteria, 
was used to intoxicate sheep to study mastitis-related reproductive failure, mediated by 
TNF- α.  Estrus was synchronized in ten adult Suffolk ewes.  Four days after mating (Day 
0) the jugular and posterior vena cava (saphenous vein) were catheterized.  On Day 5, 
ewes were assigned randomly to either: control group (n = 4, 0.9% NaCl), or PG-PS 
group (n = 6, 30µg/kg BW, i.v.).  Plasma samples were collected from both jugular and 
saphenous vein catheters every 15 minutes for 6 hours. Radioimmunoassay quantified 
concentrations of TNF-α.  Data were analyzed using repeated-measures analysis of 
variance.  Intoxication of day-5 pregnant ewes with 30 µg/kg BW PG-PS induced 
significant (p< 0.0021) increases in TNFα concentration in the venous blood draining the 
reproductive tract (posterior vena cava), but not in jugular blood, demonstrating that 
injection of PG-PS systemically leads to local production of the inflammatory cytokine, 
TNF-α.  
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Literature Review 
Introduction 
 Breeding efficiency in dairy cows can be reduced at multiple levels:  timing of 
ovulation, failure to ovulate, failure to manifest estrus, viability of gametes, embryonic 
survival, and fetal development (Stott and Williams, 1962).  Inskeep and Dailey (2005) 
stated that estimated embryonic death at day 3 after insemination would be 33% of, and 
further embryonic death would occur in 15% of, first inseminations.  It has become 
widely accepted that much of the pregnancy loss in cattle is due to early embryonic death, 
wherein embryos are most susceptible to mortality during development from the morula 
to blastocyst stage on days 5 through 8.  In multiparous cows, 67% of embryonic loss 
occurred by day 8, whereas 92% of the estimated loss was seen by day 8 in nulliparous 
females (Inskeep and Dailey, 2005).  Thatcher et al. (1994) concluded that approximately 
30% of repeat breeder cows experienced embryonic loss by day 7 of pregnancy.  Repeat 
breeding ewes tend to have  similar losses (Quinlivan et al., 1966). 
“Abortions during early pregnancy result in increased days open at a cost of at 
least US $2.00 to $5.00 per day.  An early pregnancy loss causing an increase of 45 days 
open may result in a loss of between $90 and $225.  If 20% of a 200 cow herd abort[s], 
the loss could be as much as $4500” (Kirk, 2006).  The associated risk is an extended 
calving interval which reduces production.  By increasing the calving interval from 12 to 
13 months, there is a 2-5% loss in the beef herd’s potential calf production, and  calving 
intervals of over 14 months will produce losses of greater than 10% in average producing 
dairy herds (Kirk, 2006).  Louca and Legates (1968) stated that yield per unit of time; i.e. 
milk per day or per year is more important than total lactation production; days open 
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caused a decrease of 2.40 + 1.09 kg of milk and 0.112 + 0.040 kg of fat for each 
additional day open.  Although there is general agreement that calving interval should be 
approximately 12 months, many believe that the length of the calving interval should 
depend on the age of the cow and her producing ability and should not be the same for all 
cows.  Maximizing conception rates at the first insemination postpartum will accomplish 
this task (Leslie et al., 1986).   
Alarmingly, pregnancy rates in dairy cattle have decreased from 50-60% in the 
1970s to 35-45% (Hansen et al., 2004).  One hypothesized cause of these losses is that an 
onset of infection due to bacteria and multiple other environmental factors results in 
embryonic loss.  The innate immune system is poised to recognize and respond to the 
earliest stages of infection. Because pathogens differ greatly in their structures and means 
of pathogenesis, the host’s innate immune system must have diverse ways of dealing with 
all types of pathogens (Janeway et al., 2001). A key component of the host innate 
immune response is up-regulation of cytokine production.  The well-described 
proinflammatory cytokine, tumor necrosis factor alpha (TNF-α), mediates the 
inflammatory response at both local and systemic levels (Bannerman et al., 2004).  
Production of TNF-α has been implicated in direct actions mediating embryonic loss 
(Stewart et al., 2003), and indirect actions (Erlenbacher et al., 2004) wherein TNF-α 
alters physiological concentrations of reproductive hormones necessary for gestation.   
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I. Embryonic Development  
A. Morphological Events 
A mammalian oocyte is a large haploid cell surrounded by a protective 
extracellular layer, the zona pellucida, and by granulosal cells organized into the corona 
radiata.  Entry of the oocyte into meiosis in the fetal ovary is accompanied by DNA 
synthesis analogous to S phase in mitotic cells.  Meiosis proceeds up to the first prophase 
and is arrested, just prior to or shortly after birth in most mammals.  After puberty, 
meiosis is reinitiated, and oocytes complete the first meiotic division with formation of 
the first polar body. They become arrested at second metaphase of meiosis until 
completion of the second meiotic division is triggered by sperm penetration at 
fertilization (Dekel, 1998) in the ampulla of the oviduct (Dalton et al., 1994).  After 
fusion of the sperm and oocyte, the diploid chromosome number is restored, and a 
complex program of gene activity directs embryogenesis (Blandau, 1961, Schatten, 
1998).  
 Cleavage in mammals consists of a series of mitotic divisions spaced at 
approximately 12-hour intervals.  The cell divisions during cleavage are unusual in that 
no cellular growth occurs between successive divisions.  Early cleavage in mammals 
occurs while the embryo is in the oviduct and still in the zona pellucida.  During the first 
cleavage, two identical cells, blastomeres, are produced. Initiation of gene transcription 
from the zygotic genome occurs at this stage in the mouse embryo, whereas in other 
species maternal factors (mRNA and proteins) control early embryonic development as 
the onset of zygotic transcription is delayed.  Every subsequent cell division is 
asynchronous.  At the eight cell stage, cells flatten, become compact, and increase cell to 
cell adhesion via structures known as tight junctions.  At this stage, morula, the embryo 
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organizes the cells into the inner cell mass and the outer cell mass (trophoblast).  At the 
thirty-two cell stage, the embryo enters the uterus. Between the thirty-two and sixty-four 
cell stage, now termed a blastocyst, the outer trophoblast layer differentiates and 
transports fluid from the outside to the inside of the embryo; this fluid filled cavity is 
called the blastocoel.  As the cells of the blasocyst continue to divide (64 -128 cell stage), 
the blastocoel fills with fluid and the enzymatic activity along with pressure exerted by 
the expansion permits the embryo to escape the zona pellucida, termed hatching.  The 
embryo settles onto the epithelium that lines the uterus, triggering the implantation 
process (Burdsal, 1998).   
After hatching the conceptus undergoes massive growth.  At day 13 in the cow, 
the blastocyst is 3 mm in diameter, and during the next 4 days the blastocyst will grow to 
250 mm in length.  In domesticated animals, the preattachment period is long.  During 
this time, extensive extraembryonic membranes are formed by a fusing process that 
generates the amnion, chorion, and allantochorion.  The pig, sheep, and cow have a 
filamentous or threadlike blastocyst prior to attachment.  Formation of the 
extraembryonic membranes is an obligatory step in the embryo’s ability to attach to the 
uterus of the dam.  The trophoblast, along with primitive endoderm and mesoderm, gives 
rise to the chorion and the amnion.  The yolk sac develops from the primitive endoderm.  
The chorion will eventually attach to the uterus, while the amnion will provide a fluid-
filled protective sac for the developing fetus.  In the cow and sheep, the conceptus does 
not implant or bury itself, but rather attaches to the endometrial surface.  The chorionic 
villi, small finger-like projections that are on the surface of the chorion, attach to the 
maternal caruncular tissue in the endometrium of the dam (Senger, 1999).   
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B. Endocrinology of Early Embryonic Development 
 Progesterone secretion by the corpus luteum (CL) must be maintained at 
sufficiently high rates so that attachment can occur.  The embryo enters the uterus 
between days 2 and 5 after ovulation; a critical series of events including the conceptus 
signaling to the dam, and maternal recognition of pregnancy must occur to prevent 
concentrations of progesterone from decreasing.  As reviewed by Goodman and Inskeep 
(2006), in ewes and cows progesterone from one cycle and the subsequent rise in 
estrogen at estrus prevent premature release of PGF2-α in the next cycle. As reviewed by 
Senger (1999), the CL of ruminants produces oxytocin which stimulates endometrial cells 
to synthesize prostaglandin (PGF2-α) and initiate luteolysis.  The production of PGF2-α 
is dependant on the number of oxytocin receptors on the endometrial cells during the 
estrous cycle.  When these receptors are available in sufficient numbers, secretion of 
PGF2-α and luteolysis occur. However, data reviewed by Goodman and Inskeep (2006) 
cast doubt on the requirement for luteal oxytocin in luteal regression in ruminants.   They 
cite that depletion of oxytocin from bovine CL before luteolysis had no effect on duration 
of the estrous cycle, and oxytocin did not stimulate secretion of PGF2-α by endometrial 
explants from either cyclic or pregnant cows on day 17 post-estrus.   Treatment of 
ovariectomized ewes with progesterone and estrogen (mimicking the luteal phase) caused 
a release of platelet-activating factor (PAF) into the uterine lumen; exogenous PAF 
stimulated secretion of PGF2-α, as measured by PGFM (Chami et al., 1999).  Goodman 
and Inskeep (2006) speculated that the synergism of PAF and oxytocin could account for 
the high amplitude of secretion of PGF2-α during luteolysis in the ewe.  
  In the ewe and cow, the free floating blastocyst produces specific proteins that 
signal the prevention of luteolysis; these proteins belong to a class known as interferon, 
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mostly nonspecific glycoprotein produced by leukocytes, fibroblasts, lymphocytes, and 
trophoblastic cells.  Ovine and bovine interferon-tau binds to the endometrium and 
inhibits oxytocin receptor synthesis by endometrial cells. In addition to blocking oxytocin 
receptors, interferon-tau binds to the apical portion of the uterine glands and promotes 
protein synthesis, which is believed to be critical for embryonic survival.  In the sheep, 
maternal recognition occurs on days 13-14 after ovulation and attachment on day 15-18 
occur (Senger, 1999).   
Paria et al. (2001) stated that in mice and rats there seems to be no evidence that 
estrogen and/or progesterone act directly on the preimplantation embryo; embryonic 
development is considered to depend on growth-promoting factors originating from the 
reproductive tract under the influence of these hormones.  However, normal development 
in defined media in cultures indicates that preimplantation embryos themselves produce 
growth promoting factors and cytokines. Dalton et al. (1994) showed that several growth 
factors can exert pleiotropic effects during preimplantation of the mouse embryo; and 
suggested that oviductal growth factors and embryo-derived growth factors contribute to 
an optimal environment for preimplantation embryonic development.  
II. Mammary Gland Growth and Endocrinology  
 Between onset of puberty and pregnancy, the mammary gland grows 
disproportionately faster than normal body growth, known as allometric growth.  During 
the first several estrous cycles, under the influence of estrogen, the mammary duct 
increases in diameter.  Under the influence of progesterone the terminal portions of each 
branch form functional secretory elements - alveoli.  Prolactin and growth hormone 
(somatotropin) promote further development of the alveoli, and complete development of 
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the mammary gland occurs during the last trimester of pregnancy when the terminal 
alveoli grow into [bunches called] lobules (Senger, 1999).  Prolactin, adrenal cortical 
hormones, and placental lactogen are important in allowing the mammary epithelium to 
synthesize milk (Akers, 2000).  Milk ejection, the active transfer of milk from the alveoli 
and alveolar ducts into the larger mammary ducts, cisterns, and teat, is a neuroendocrine 
reflex usually requiring suckling by the neonate (or mechanical stimulation) to initiate the 
cascade.  Upon stimulation of the teat, sensory neurons transmit a signal to the 
brain/hypothalamus/posterior pituitary. The latter secretes oxytocin that is delivered to 
the myoepithelial cells, which surround the alveolus and have receptors for oxytocin.  
The myoepithelial cells contract and squeeze the milk which has been secreted from the 
alveolar cell into the alveolar lumina, into small ducts, from which it is transported into 
larger ducts, i.e. the delivery of milk to the neonate (Senger,  1999).   
III. Characteristics of Mastitis 
Mastitis is the inflammatory response of milk-secreting tissue to injury produced 
by physical force, chemicals introduced into the gland, or most commonly intra-
mammary infection from bacteria and their toxins (Swartz, 2006).  Mastitis is the most 
devastating disease affecting adult dairy cows, and the associated economic losses, an 
estimated $2 billion annually in the United States (Hockett et al., 2005); continue to 
present a serious burden to producers. Sordillo et al. (1997) estimated that mastitis affects 
one-third (1.5 quarters) [sic] of every dairy cow. 
Clinical mastitis can be characterized by decreased milk production and increased 
numbers of leukocytes in milk, altered milk composition, increased  body temperature, 
and red, warm, and/or swollen mammary quarters (Hansen, 2004).    The degree of 
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inflammation is diagnosed visually or palpably, and subclinical infections are diagnosed 
by assessments of somatic cells and/or bacteria present in milk (Swartz, 2006).  Direct 
microscopic somatic cell counts (DMSCC) provide the most accurate means of assessing 
the degree of inflammation, but this is a rather slow laboratory procedure.  Somatic cell 
counts, which electronically provide a more rapid technique, still need to be tested in the 
laboratory.  The California Mastitis Test allows for “cow-side” assessment and is the 
preferred method for dairymen (Keisler et al., 1992).   
There are certain times in the lactation cycle when mammary gland defenses fail 
to operate properly and cows become more susceptible to mastitis.  Staphylococcus 
aureus (gram positive bacteria) and Esherichia coli (gram negative bacteria) account for 
the majority of clinical mastitis in cattle, which occurs most frequently during early 
lactation (Bannerman et al., 2004).  However, some of these infections originate during 
the non-lactating period and result in clinical mastitis during the first 30 to 60 days after 
calving. Moreover mastitis can reduce reproductive efficiency; as manifested by 
increased days to first service, days open, and services per conception (Barker et al., 
1998).  Cows with clinical mastitis between first artificial insemination (AI) and 
conception required an additional AI, which lengthened the breeding period and the 
number of days to conception (Barker et al., 1998).  Intramammary injection of an 
endotoxin to mimic a clinical mastitis infection induced luteolysis and influenced 
conception and early embryonic survival presumably by the release of inflammatory 
mediators (Schrick et al., 2001) and could stimulate production of prostaglandin F2-α, 
which subsequently would cause luteal regression.   
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IV. Peptidoglycan-Polysaccharide Complex Characteristics 
 Wang et al. (2000) concluded that gram positive and gram negative bacteria have 
similar manifestations such as inflammation, fever, leukocytosis, hypotension, decreased 
peripheral perfusion, malaise, decreased appetite, sleepiness, and arthritis. The common 
cell wall component of both gram positive and gram negative bacteria is peptidoglycan 
also known as glycopeptide, mucopeptide or murein (Holaskova et al., 2004).  As cited 
by Rosenthal (1994), peptidoglycan is a thick rigid layer composed of an overlapping 
lattice of two sugars, N-acetyl glucosamine (NAG) and N-acetyl muramic acid (NAM), 
that are crosslinked by amino acid bridges, generally the same four amino acids- L-
alanine, D-alanine, D-glutamic acid, and diamino pimelic acid (DPA).  The degree of 
cross-linking determines the degree of rigidity.  In gram positive bacteria, peptidoglycan 
is a heavily cross-linked woven structure that wraps around the cell with its thickness in 
the range of 20-80 mm; the form of which determines the organism’s shape (bacilli, 
cocci, or spirilla).  The thick peptidoglycan layer in gram positive bacteria is sensitive to 
the action of lysozyme and penicillin, which is often the antibiotic of choice for 
infections caused by gram positive organisms (Rosenthal, 1994).  Lysozyme, a principle 
protein of phagocytes, is an enzyme that degrades the polysaccharide protective coating 
on the surface of many bacteria and viruses (glycoprotein) to allow other enzymes and 
antibodies to bind at specific attachment sites.  Lysozyme is ubiquitous in infected tissue 
and by lysing peptidoglycan makes bacteria susceptible to osmotic and mechanical 
stressors (Ganz et al, 2003).    
 Peptidoglycan administered as an intoxicant elicited similar results as whole 
bacterium (Stewart et al., 2003; Holaskova et al., 2004).  Peptidoglycan, has biological 
actions similar to endotoxin, the cell wall component of gram negative bacteria.  Rotta 
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(1975) reported that peptidoglycan, like endotoxin, causes pyrogenic responses in rabbits 
which can be eliminated by administering antiserum to peptidoglycan in a dose-
dependant manner.  Dziarski (1979) found peptidoglycan to be a potent B-cell mitogen in 
mice; mitogens and polyclonal B cell activators stimulated lymphocytes in a nonspecific 
manner i.e. without participation of antigen-specific receptors (the variable part of 
immunoglobulin in the case of B lymphocytes).  Besides its pyrogenic and mitogenic 
characteristics, Holaskova et al. (2004) cited that peptidoglycan is a main immunogenic 
component of gram positive bacteria wherein it activates macrophages and the 
complement pathway.   Briefly, the complement pathway is made up of a large number of 
distinct plasma proteins that react with one another to opsonize pathogens and induce a 
series of inflammatory responses that help to fight infection.  The complement system is 
activated through a triggered enzyme cascade and results in the opsonization of 
pathogens, recruitment of inflammatory cells, and direct killing of pathogens (Janeway, 
2001). 
V. Innate Immune System and the Toll-like Receptor Pathway 
 The innate immune system represents the first line of defense of the host to 
infection and is poised to recognize and respond to the earliest stage of infection. The 
innate immune system responds within 0 to 4 hours once bacterial pathogens enter the 
host to recognize and remove infectious agents by using preformed nonspecific effectors: 
antimicrobial proteins, peptides, phagocytes, natural killer cells, activated macrophages, 
cytokines and complement (Janeway, 2001).   “The inherent capability of the innate 
immune system to respond to a large number of pathogens is mediated by its ability to 
recognize highly conserved motifs shared by diverse pathogens” (Bannerman et al., 
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2004).  Motifs referred to as pathogen-associated molecular patterns (PAMPs) include 
bacterial cell wall components, i.e. peptidoglycan. The PAMPs are composed of 
polysaccharides and polynucleotides that differ little from one pathogen to another but 
are not found in the host.  Macrophages and neutrophils recognize pathogens by means of 
cell surface receptors that discriminate between PAMPs of various pathogens and self.  
The innate immune system senses invading pathogens by germ-line encoded pattern 
recognition receptors (PRRs, Takeuchi et al., 2001).  Pattern recognition receptors and 
their corresponding PAMPS are evolutionarily conserved (Bannerman et al., 2004).   
Pattern recognition receptors have three groups: secreted molecules that circulate 
in the blood and lymph, surface receptors on phagocytic cells, like macrophages, that 
bind the pathogen for engulfment, and cell-surface receptors that bind the pathogen, 
initiating a signal leading to the release of effector molecules, i.e. cytokines.  Toll-like 
receptors (TLRs), an example of cell surface receptors, are present on the outside of 
macrophages, dendritic cells, and epithelial cells, to name a few.  Those receptors 
identify the nature of the pathogen and turn on an effector response appropriate for 
signaling cascades that lead to the transcription of various cytokine genes (Ozinsky, 
2000; Pioli et al., 2004; Supajatura et al., 2001; Takeuchi et al., 2001; Underhill et al., 
1999).  Toll-like receptors are type one transmembrane receptors characterized by the 
presence of extracellular leucine-rich repeat motifs and a cytoplasmic Toll/IL-1R (TIR) 
homology domain, which is required for the signaling that leads to the activation of a 
transcription factor, nuclear factor (NF)-κB (Takeuchi et al., 2001).  In Medzhitov’s and 
Janeway’s (2000) immunological review, they stated that, in human beings, TLRs result 
in recruitment of an adapter protein (AP), MyD88 that binds to the cytoplasmic TIR 
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domain, which then recruits interleukin (IL)-1 receptor-associated kinase (IRAK), a 
serine/threonine protein kinase. Once the MyD88 and IRAK receptor complex is formed, 
IRAK is autophosphorylated and then disassociates from MyD88.   MyD88 associates 
with another AP, TNF receptor-associated factor 6 (TRAF6), which activates several 
members of mitogen activated protein kinase kinase kinase (MAP3K) family, namely 
NF-kB.  Once NF-kB is activated, it translocates to the nucleus of the cell and transcribes 
of inflammatory cytokines.    
Of the 10 cloned mammalian TLRs, TLR2 and TLR4 are the best characterized 
with respect to innate responses to bacteria (Pioli et al., 2004).  A broader range of 
microbial products activate immune responses through engagement of TLR2 and TLR6, 
including peptidoglycan from gram-positive bacteria, bacterial lipopeptide, 
mycobacterium, and zymosan, a yeast cell wall particle (Pioli et al., 2004; Supajatura et 
al., 2001; Takeuchi et al., 2001; Underhill et al., 1999).  Together, TLR2 and TLR6 
coordinate macrophage activation by gram positive bacteria, peptidoglycan, and zymosan 
(Ozinsky, 2000).  Toll-like receptor 2 needs a partner molecule to activate TNF-α 
production in macrophages (Ozinsky, 2000).  It can form functional pairs with TLR6 or 
TLR1, and this interaction induces to cytokines (Ozinsky, 2000).  In their study, 
Takeuchi et al. (2001) used TLR2 -/-  and TLR6 -/- mice to demonstrate that TLR2 and 
TLR6 are both needed to activate NF-kB during infection with mycoplasmal 
macrophage-activating lipopeptide-2kD (MALP-2), a bacterial lipoprotein.   
The main targets of peptidoglycan are monocytes and macrophages which are 
activated by two pattern recognition receptors: CD14 and Toll-like receptors (Wang et 
al., 2000).  Given the microbial diversity of the female reproductive tract, Pioli et al. 
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(2004) investigated the role that TLRs play in mediating innate immune recognition in 
the fallopian tubes, uterus, cervix, and ectocervix.  Expression of TLR2 was higher in the 
cervix and fallopian tubes than in the uterus or ectocervix in human beings.  Pioli et al. 
(2004) further stated that TLR2 expression, while constitutively low, can be induced post 
infection and that TLR2 expression can be augmented by TNF-α.  They proposed that 
TLR2 expression may be up-regulated in response to pathogenic challenge as a defense 
mechanism to protect the fetus from infection during pregnancy and labor.    
VI. Cytokines and Acute Phase Proteins   
 The main proinflammatory mediators induced by bacteria and their cell wall 
components are cytokines, primarily TNF-α, IL-1, and IL-6 (Wang et al., 2000).  During 
inflammatory responses (characterized by pain, redness, heat and swelling, at the site of 
infection) blood flow is increased due to an increase in vascular diameter. Endothelial 
cells lining blood vessels are activated to express adhesion molecules that promote 
binding of circulating leukocytes, and endothelial cells become separated leading to the 
exit of fluid and proteins, which cause edema. These changes are mediated by cytokines, 
which generally act over small distances, in short time spans, and at very low 
concentrations unless stimulated (Janeway, 2001).  Cytokines are of particular 
importance in mediating communications between the conceptus and maternal cells, 
particularly the uterine epithelium and infiltrating leukocytes, both prior to implantation 
and as the placenta develops (Robertson et al., 1994).   
A potent activator of endothelial cells (Janeway, 2001), TNF-α is a non-
glycosylated protein with a molecular weight of 17kDa (Okuda et al., 2003).  First 
described as a tumoricidal factor produced by activated macrophages, TNF-α, has 
  14
biological actions including proinflammatory mediator, cell differentiation control, 
renewal and reconstruction of tissue.  It belongs to the TNF superfamily of 18 members, 
which have conserved C domains in common; this trimeric domain is responsible for 
receptor binding and has 20-30% sequence homology with the rest of the family (Okuda 
et al., 2003).  Arslan et al. (2004) showed increased levels of TNF-α concentrations in 
serum in 14 of 20 women who were pregnant less than 20 gestational weeks and had a 
past history of recurrent abortion and in 6 of 20 nonpregnant women with a past history 
of habitual abortion, compared to 2 of 20 healthy, nonpregnant women.  The TNF-α  
could cause an increase in the synthesis of prostaglandins, hence uterine contractions, and 
have an important role in apoptosis, affect the implantation of embryos, and decrease 
blood flow to the embryo by causing thrombosis (development of clot in vein or artery) 
in the vessels.   
The inflammatory effects of TNF-α, IL-1 and IL-6 initiate the acute phase 
response.  For a general definition; the acute-phase of the inflammatory response refers to 
the wide-ranging physiological changes that are initiated immediately after an infection 
or physical trauma has occurred.  “The mammalian acute phase response (APR) is 
characterized by fever, changes in vascular permeability; along with changes in the 
biosynthetic, metabolic and catabolic profiles of organs; the response is initiated and 
coordinated by a large number of diverse inflammatory mediators which include 
cytokines, anaphylatoxins, and glucocorticoids” (Paape M.J., et al., 2002).  Cytokine’s 
actions on hepatocytes in the acute-phase response involve a shift in protein synthesis, 
acute-phase proteins (APP), which are secreted by the liver into the blood plasma in 
response to cytokines released by macrophages in the presence of bacteria (Janeway, 
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2001).  The APP are of particular interest because they mimic the actions of antibodies. 
However, unlike antibodies, these proteins have a broad range or specificity for PAMPs 
and depend on cytokines for production.   
One of the APP, serum amyloid A (SAA) in humans can exhibit dramatic 
increases in serum concentrations in response to inflammatory stimuli, and thus has been 
used as an inflammatory biomarker (Sasaki et al., 2003).  Sasaki et al. (2003) stated that 
there is a high degree of conservation of SAA genes and proteins that have been 
maintained through evolution of eutherian mammals, which provides further evidence 
that they are likely to have important biological functions.  Plasma haptoglobin (HP) and 
SAA are the two major biomarkers of the acute phase response to immune stress in cattle 
(Kahl and Elsasser 2005).  Vogels et al. (1993) cited that acute-phase proteins, which are 
synthesized by the liver during a variety of acute inflammatory processes, may operate as 
oxygen radical scavengers, protease inhibitors, coagulation factors, and opsonins, and 
may therefore play a role in the nonspecific defense of the host to infection.  Van der 
Meer et al. (1988) showed that a single dose of IL-1 administered at 24 hours, but not 6 
or 0.5 hours, before a lethal gram negative bacterial infection enhanced survival due to 
the increased production of acute-phase proteins, which appear to balance or curtail the 
potential adverse consequences of the inflammatory process and restore homeostasis.  
Vogels et al. (1993) showed that D-galactosamine (GALN), a liver specific blocker of 
RNA and protein synthesis which acts by depleting UTP and thereby is able to block 
protein synthesis in the acute phase of infection, completely blocked IL-1-induced 
synthesis of acute-phase proteins. 
  16
VII. Immunology of Maternal-fetal Interface 
Numerous investigators have used CBA/J females mated with DBA/2 males 
(CBA/J X DBA/2), which spontaneously resorb 20-30% of litter, to examine the role of 
the immune system during mammalian pregnancy (Duclos et al., 1995; Chaouat G. et al., 
1990; Gendron et al., 1990; Baines et al, 1996, 1997).  Duclos et al. (1995) demonstrated 
that after the mating of CBA/J X DBA/2 the majority (69.4%) of embryos, representing 
embryos that are not spontaneously resorbed during pregnancy, expressed low amounts 
of the macrophage-specific marker, F4/80+.  However after the mating of CBA/J X 
DBA/2, 30.6% of embryos, representing the 20-30% of embryos that are spontaneously 
resorbed, expressed much higher amounts of F4/80+, confirming the presence of 
macrophages at the feto-placental interface of resorbing embryos. Moreover, Duclos et al. 
(1995) stated that TNF-α could be involved in a positive feedback loop and recruit 
effector cells to the site of fetal distress.  “The maternal response responsible for embryo 
loss primarily depends on the activation of the maternal innate immune system (natural 
killer (NK cells), activated macrophages, neutrophils) as opposed to the specific maternal 
acquired immune response mediated by helper T cells (Th1 and Th2), cytolytic T cells, 
and antibodies (Baines et al., 1997). 
 In human beings, leukocytes account for roughly 10% of stromal cells in the 
proliferative phase, 20% in the secretory phase, and 30% of endometrial stromal cells in 
early pregnancy (deciduas) (Dosiou and Giudice, 2004).  The largest population in the 
endometrium consists of (NK) cells named large lymphocytes; which comprise over 70% 
of endometrial leukocytes (30% of stromal cells) during the first trimester.  The increase 
of uterine NK (uNK) cells during pregnancy is due mainly to recruitment of uNK cell 
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precursors from spleen, lymph nodes, and bone marrow and not from self renewal of 
existing uNK populations.   Dosiou and Giudice (2004) further stated that human 
trophoblast cells are resistant to lysis by uNK cells, unless the latter have been stimulated 
by IL-2; however IL-2 is not present in the endometrium to any great extent during 
normal pregnancy.  In their summary, they stated that uNK cells produce a variety of 
cytokines capable of directly influencing trophoblast growth and hormone production as 
well as implantation and vascularization of the decidua.   
VIII. Pregnancy Loss Due to Endotoxin and Peptidoglycan 
 A. Endotoxin-Induced Pregnancy Loss 
Animals show greater susceptibility to bacterial pathogens during pregnancy, and 
both endotoxin and peptidoglycan lysed from bacterial pathogens have lead to abortion 
and in the most severe cases, death of the dam (reviewed by Holaskova, 2002).  Duclos et 
al. (1995) cited reports that modulation of innate resistance had observable effects on 
reproduction in contrast to the minimal effect of specific immune modulation, which 
strengthens the argument that the nonspecific (NK cells and macrophages) innate 
mechanisms may play a more important role in mammalian reproduction, at least early 
during pregnancy.   
Macrophages initiate synthesis and release of massive amounts of TNF-α when 
activated by endotoxin/LPS (Hunt et al., 1996; Silver et al., 1994).  Hunt et al. (1996) 
stated that TNF-α is thought to be an abhorrent molecule that should be avoided at all 
costs during pregnancy; administration of LPS or a large bolus of TNF-α to pregnant 
animals caused massive hemorrhage and pregnancy termination. TNF-α is produced by 
decidual explants in response to LPS (in vitro); high levels of TNF-α in human amniotic 
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fluid are associated with infection and preterm labor.  Placental and extra-placental 
membranes contain a large population of both macrophages and NK-like cells.  Thus, 
Hunt et al. (1996) concluded that the high concentrations of TNF-α produced during 
chorioamnionitis and maternally transmitted bacterial diseases probably result from 
activation of those leukocytes, particularly the macrophages.   
Silver et al. (1994) used an LPS-hyporesponsive murine strain (C3H/HeJ) to 
establish whether LPS-induced death was due to a maternal or fetal response to LPS, and 
also investigated the involvement of TNF-α in fetal death caused by LPS. They 
concluded that LPS caused fetal loss via a maternal effect as opposed to a direct fetal 
effect, because there was no LPS-induced fetal loss in endotoxin-resistant mothers even 
when fetuses were genetically endotoxin-susceptible.  Silver and coworkers speculated 
that [this] resistance to LPS-induced fetal death in C3H/HeJ mice [was] at least partially 
due to impaired TNF-α production/secretion in response to LPS intoxication.  They 
speculated that TNF-α-induced fetal death is via the elaboration of prostaglandins; 
eicosanoids are known abortifacients and are produced by gestational tissues in response 
to TNF-α.  Fetal death caused by LPS administration appears to be due to a maternal 
response as opposed to a direct fetal effect, therefore suppression of the maternal immune 
response, particularly the actions of TNF-α, may improve fetal outcome in cases of 
maternal bacterial infection (Silver et al., 1994).  Gendron et al. (1990) showed that 
concentrations of LPS-induced TNF-α were reduced by 90% after pretreatment with the 
TNF-α suppressing drug, pentoxifylline (PXF), in CBA/J X DBA/2 mice on Day 8 of 
gestation. Further, the effects of LPS appeared to be uterine-specific, as no other tissues 
showed any gross signs of pathology.     
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 B. Peptidoglycan-Induced Pregnancy Loss    
 Bacteria lysed in the host release peptidoglycan, which elicits an immune 
response that has been found to be detrimental to pregnancy (Stewart et al., 2003; 
Holaskova et al., 2004).  Similarly to LPS, peptidoglycan-polysaccharide (PG-PS) 
induced production of prostaglandins and those factors, and not fever, increased cortisol, 
or decreased progesterone secretion, reduced pregnancy rates of treated versus control 
ewes (Stewart et al., 2003).  Fortunato et al. (1998) showed that PG-PS induced 
expression of IL-6 and  IL-8, and that LPS induced an even greater secretion of IL-6 and 
IL-8 in amniochorion membranes.  They suggested that the cytokine profile differed 
based on the types of bacterial isolate, population size and the type of toxin/enzyme 
generated, which [might] help in designing strategies for understanding and controlling 
infection associated with preterm labor.   
VIIII. Embryotoxicity 
 Baines et al. (1997) showed that early embryo loss is mediated by the in vivo 
triggering of primed decidual macrophages; the precise relationship between decidual NK 
(uNK) cells and macrophages is not fully understood. However, primed uNK cells can 
produce IFN-γ which can activate macrophages capable of producing increased quantities 
of TNF-α and nitric oxide (NO) if triggered by exposure to LPS or TNF-α.  Although 
Baines et al. (1997) expected that embryos in the later stages of resorption would have 
large infiltrates of cells producing TNF-α and nitric oxide,  approximately 20-30% of 
CBA/J X DBA/2 F1 embryos collected between 6 and 8 days of gestation showed 
increases in uNK cells and activated macrophage infiltrates expressing messages for 
inducible nitric oxide synthase (iNOS), TNF-α, and IFN-γ.  Haddad et al. (1997) stated 
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that NO is a short-lived pleiotropic mediator that is synthesized from L-arginine by 
constitutive or inducible NOS; iNOS is inducible by IFN-γ, TNF-α, IL-1, and LPS.   
Previous work (Haddad et al., 1995) observed maternal macrophages at the implantation 
sites of  29% of embryos (day 12) produced significant amounts of nitrate and nitrite, the 
oxidation products of NO in response to LPS, and that embryo survival was dramatically 
enhanced in pregnant CBA/J mice treated with an NOS inhibitor, aminoguanidine, 
indicating that NO was essential for embryonic loss in their model.  Haddad et al. (1997) 
showed that as soon as day 8 of gestation 32% of embryos had increases of iNOS mRNA 
and 29% of embryos had increases of TNF-α mRNA, with no apparent pathology. These 
results provide evidence for the presence of activated macrophages at implantation sites 
before overt embryo damage occurs.  TNF-α has been shown to be involved in fetal 
resorption; TNF-α  is a multifunctional cytokine produced by a variety of cell types.  
Depending on stimulus and cellular target TNF-α has cytotoxic, cytostatic, 
immunomodualtory, growth promoting and many other activities (Haddad et al., 1997).  
They further stated that exogenous TNF-α could induce abortion and that inhibition of 
TNF-α production by anti-TNF-α or pentoxifylline increased embryo survival.   
Pampfer et al. (1995) demonstrated that blocking the expression of TNF-α Rp60 
(TNF receptor) protected rat blastocysts from TNF-α.  Further, average cell number 
detected in inner cell mass and trophblast lineages decreased after exposure to TNF-α in 
the presence of sense oligonucleotides to TNF-α Rp60, but the effect was fully prevented 
with the antisense version of the same oligonucleotide.  Pampfer et al. (1995) suggested 
that the negative effect of TNF-α in rat blastocysts was mediated solely by TNF-α Rp60 
and not second type of TNF-α receptor Rp80; the current consensus is that activation of 
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TNF-α Rp60 alone is sufficient to trigger most of the biological activities of TNF-α and 
that TNF-α Rp80 acts only as an accessory component to TNF-α Rp60 to facilitate or 
amplify a small subset of effects.     
Baines et al. (1996) reported that prior immunization with both paternal specific 
MHC and non-specific antigen LPS and complete Freund’s adjuvant (CFA) decreased the 
frequency of spontaneous early embryo resorption in murine pregnancy.  However, 
Baines et al. (1996) found that none of the immunotherapeutic vaccinations or matings 
had a permanent effect on CBA/J X DBA/2 embryo survival, which is what one would 
expect if specific immune mediators were involved. It was speculated that CFA had a 
role in decreasing the frequency of spontaneous resorption in CBA/J X DBA/2 mice.  
However, the embryo enhancing effect of prior immunization with CFA was limited to a 
few weeks; similarly, LPS immunization protected embryos from LPS-induced early 
embryonic abortion, but was short lived (Baines et al., 1996).   
Effects of TNF-α have not been characterized using PG-PS.  Stewart et al. (2003) 
showed an increase in PGFM from controls upon administration of PG-PS  in day-5 
pregnant ewes at 15, 30 and 60 ug/kg BW dosages.  Additionally, Stewart et al. (2003) 
noticed decreases in progesterone during this time.  This is in accordance with Costine et 
al. (2001) who showed that early regressing corpora lutea had embryotoxic effects 
despite progestogen supplementation in ewes.  Chronic treatment of ewes with exogenous 
PGF2-α reduced embryonic survival despite progestogen replacement therapy and ewes 
that were lutectomized had higher pregnancy rates than ewes that were sham 
lutectomized.  Holaskova et al. (2004) showed that immunization with PG-PS in ewe 
lambs had cumulative effects decreasing pregnancy rate with increased exposure to PG-
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PS.  It has been suggested through the work of Stewart et al. (2003) and Holaskova et al. 
(2004) that the early embryonic loss in the PG-PS intoxicated ewe model works through 
the same direct and indirect mechanisms as in the LPS-induced early embryonic loss 
models i.e. through increases in concentrations of PGF2α and TNF-α. Kahl and Elsasser 
(2005) cited several lines of evidence that the outcome of some infections may be aligned 
with, and perhaps predicted by, plasma concentrations of cytokines during disease, 
particularly tumor necrosis factor (TNF-α).  Transient bursts of TNF-α production are 
essential for initiating critical mediator response cascades of other cytokines, 
arachidonic/eicosapentanoic acid compounds, acute phase response proteins, nitric oxide 
and adrenomedullin.   
X. Summary 
 There are several homeostatic changes to consider after a systemic intoxication of 
PG-PS early (day 5) pregnant ewes.  First, after PG-PS intoxication [into] the jugular 
vein, the bacterial cell wall component, PG-PS, enters systemic circulation.  Once inside 
the host’s circulation the individual bacteria, in this case the cell wall component PG-PS, 
homes to its predetermined preferential location.  This is a unique characteristic of the 
bacterium and its components.   
Second, during PG-PS intoxication, various augmentations occur to the 
hypothalamic-pituitary-gonadal axis and hypothalamic-pituitary-adrenal axis.  Stewart et 
al. (2003) have shown that in response to the PG-PS intoxication, cortisol, secreted from 
the adrenals, increases via a biphasic response.  Stewart et al. (2003) cited that cortisol 
had been shown to decrease release of pyrogenic substances from leukocytes and 
suggested that increased releases of cortisol in response to fever controlled the pyretic 
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response.  However, pregnancy loss was not a function of fever or cortisol per se, 
because ewes treated with low dosages of PG-PS maintained pregnancy.  Stewart et al. 
(2003) also found that estrogen did not increase after PG-PS dosage, but that 
progesterone [levels did] decreased in all treated ewes.  Further, Stewart et al. (2003) saw 
increases in PGFM in all treated ewes.  It was speculated that pregnancy loss was not a 
result of increased cortisol, fever, or decreased progesterone due to the fact that ewes in 
the low PG-PS dose group maintained pregnancy despite the low concentrations of 
progesterone; but that PGFM, and a potential inflammatory mediator could be 
contributing to embryonic loss (Stewart et al., 2003).    
Third, it is important to consider how the innate immune system works during the 
acute-phase response (APR).  Once PG-PS enters the host, the innate immune system 
quickly recruits cellular mediators to the site of the infection.  In the case were PG-PS 
enters the blood stream directly, PG-PS is transported to all tissues and local and 
systemic innate immune responses occur in tissues that have toll-like receptors (TLR-2) 
for PG-PS.  After recognition of the bacteria by the immune cells there is up-regulation of 
cytotoxic activity, phagocytosis, cytokine production, complement initiation, acute-phase 
protein production, and recruitment of immune cells.  Cytokine production is particularly 
important to the local innate immune response, because it perpetuates the inflammatory 
response in the local tissues so that adaptive immunity can take over.  Cytokine 
production, however, can easily get out of hand, and in response to a very large dosage of 
bacteria (lethal dosage), production of cytokines can be so high as to kill the host or cause 
severe tissue damage.   This is not frequently the case, however, when one considers a 
pregnant animal, what is not lethal to the mother can be lethal to the embryo.  
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Embryotoxicity induced by PG-PS [in] early pregnant ewes has not been described fully.  
Steps in identifying the specific characteristics of PG-PS-induced embryonic loss in 
sheep will be helpful in determining the appropriate stages at which to apply future 
therapies to prevent reproductive failure.  
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Statement of the Problem 
 Pressure has been placed on the agricultural industry to maintain high yields of 
meat and dairy products on an annual basis.  Agricultural researchers have been 
concerned with decreases in production from prolonged calving intervals due to early 
embryonic loss and have attempted to decipher causal factors for the loss.  Occurrence of 
mastitis during early embryonic development has detrimental effects on maintenance of 
pregnancy and can result in either resorption or abortion of the embryo.  Research has 
investigated associations of pathogens that cause mastitis in mediating that embryonic 
loss.   Production of TNF-α, nitric oxide and PGF2-α increase during early embryonic 
loss induced by intoxication with lipopolysaccharide (LPS), a cellular wall component of 
gram negative bacteria.   
 The primary objective of this study was to induce the protective mechanisms of 
the innate immune system by intoxicating day-5 pregnant ewes with PG-PS, a cellular 
wall component of gram negative and gram positive bacteria, and to evaluate that 
induction by measuring concentrations of TNF-α, a pivotal inflammatory cytokine, in 
venous blood both locally, from the reproductive tract, and in systemic circulation.  The 
experimental null hypothesis was that PG-PS intoxication would not result in changes in 
concentrations of TNF-α in either the jugular or [posterior vena cava].  The secondary 
objective was to profile the production of an acute phase protein, serum amyloid A 
(SAA), during PG-PS intoxication in day-5 pregnant ewes.  The associated experimental 
null hypothesis was that concentrations of SAA would not differ between treated and 
control ewes.   
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Methods and Materials 
I. Synchronization Protocol for Ewes: 
Twenty-four Suffolk ewes (average body weight 81.2 kg) from the WVU farm 
were used [in] a protocol approved by the WVU Institutional Animal Care and Use 
Committee.  Ewes were subjected to a protocol for synchronization of estrus (Inskeep et 
al., 1983) before treatment.  Briefly, a vasectomized ram with marking harness was 
placed into a pen with a maximum of 12 ewes for three days.  On the third day, unmarked 
ewes were injected (i.m.) twice with 1 mL (5mg) of PGF2α (Lutalyse®, UpJohn-
Pharmacia, Kalamazoo, MI) three hours apart.  After the second injection of PGF2α, an 
intact ram with a marking harness was placed into the pen with the ewes.  Observation 
for estrus was conducted at 12 hour intervals up to 36 hours post-injection.  A second 
replicate of 12 ewes were observed for estrus.  Estrual ewes were mated at least twice 
with the first mating termed day 0 of gestation.  In replicate 1 (September 27- October 3, 
2005), five of the seven estrual ewes were selected randomly to be placed on experiment. 
In replicate 2 (October 4 - October 10, 2005), five of six estrual ewes were selected 
randomly to be placed on experiment. 
II. Catheter Construction and Placement (Day 4 of gestation) 
a) Catheter Construction  The catheters were constructed from polyvinyl 
tubing that was measured to 80 cm in length and marked at 48, 50, and 52 cm with a 
permanent marker.  An 18 gauge needle was filed off to be inserted into the collecting 
end of the catheter.  Additionally, a filed off 1 mL syringe casing was inserted at the end 
of the needle to plug the collecting end between collections.   
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b) Catheter Placement  A catheter was placed into the caudal vena cava via the 
lateral saphenous vein, the caudal femoral vein and the external iliac.  Another catheter, 
I-CATH Intravenous Placement Unit with Stylet ® (CharterMed Inc., Lakewood, NJ), 
was used to catheterize the jugular vein.  On the evening of day 4, ewes were prepared 
for catheterization via clipping wool from the neck and hock areas and cleaning those 
areas with Betadine® (The Purdue-Frederick Company, Stamford, CT) solution.  Ewes 
were [sedated] (0.3 mg/kg BW, i.v.) with Diazepam® (Hoffmann-La Roche Inc., Nutley, 
NJ) for muscle relaxation during vena caval catheter placement, additional [sedation] was 
given as needed.  Also, the area around the saphenous vein was locally anesthetized, with 
3 to 5 mL Lidocaine® (Butler Company, Columbus, OH).  Aseptic procedures were 
followed for catheter placements; surgical instruments and saphenous vein catheters were 
soaked in Novalsan solution prior to placement.   
The saphenous vein was isolated easily by blunt dissection as described by 
Benoit, and Dailey (1991).  The saphenous vein was located approximately 3 cm lateral 
to the Achilles tendon, and could be seen through a layer of fascia after the skin was 
incised using sterile surgical blades®(Propper Manufacturing Co., Inc., Long Island City, 
NY).  Once the saphenous vein was isolated, a 16 gauge needle was used to puncture the 
vein and a catheter introducer® (Becton Dickinson and Company, Franklin Lakes, NJ) 
was utilized to allow for guidance of the pre-measured catheter into the vena cava via the 
saphenous vein.   
Blood samples were taken with heparinized tubes at 48, 50, and 52 cm, and 
catheters were pulled back and secured with internal suture at 50 cm and capped.  Briefly, 
heparinzed tubes for the experiment were made using 250 Units of Heparin® (Sigma, 
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Atlanta, GA)/ mL of 9% NaCl solution. Diluted heparin (5 mL) was vortexed inside tubes 
to coat the walls of the tubes and then residual heparin solution was discarded.  After 
blood collection special care was taken to secure the catheters to the neck and leg loosely 
with medical tape and VetWrap® (3M, St. Paul, MN).  Each ewe was placed in a lambing 
crate individually to prevent ewes from removing the catheters.  On the morning of day 5, 
ewes were removed from the individual lambing crates and assigned randomly into one 
of two larger pens.  Then the ewes were assigned randomly to one of two treatment 
groups within each pen, so that each pen had at least one treated and one control ewe.   
III. PG-PS/ NaCL Preparation, Assignment of Treatments, and Blood 
Collection (Day 5 of gestation) 
a) PG-PS/ NaCL Preparation Twenty milligrams (6.6 mg/mL) of 100P PG-PS 
were purchased (BD Lee Laboratories, Grayson, GA).   Following BD Lee Laboratories 
protocol for rats, the PG-PS was diluted with 0.9% NaCL solution to a concentration of 
0.450 mg/mL, prior to administering dosages.  Dosages of 30 ug/kg BW were given 
following the protocol of Stewart et al. (2003).   A total of 5.4 mL of diluted PG-PS was 
given to each treated ewe (n = 6) and a total of 5.4 mL of 0.9% NaCL solution was given 
to each control ewe (n = 4) as the sham inoculation.   
c) Blood Collection Heparinized tubes were made as previously described and 
stored.  Two sets of tubes were labeled: one set for the jugular vein collections and the 
second set for the saphenous vein collections.  Collection of blood into 5 mL syringes 
began at 10 am on October 8 (Week 1) and 8 am on October 15, 2006 (Week 2).  The first 
collection, roughly 5 mL of blood from each catheter, was made before intoxications to 
establish baseline.  Collections were placed into appropriate heparinized tubes and 
  29
inverted with Parafilm® (American National Can Greenwich, CT) and stored in an ice 
chest.  Intoxications were given immediately collections after baseline via the jugular 
vein.  Then, blood was collected every 15 minutes for 6 hours.  Blood was stored on ice 
until it was centrifuged and aliquots were stored at -20oC. 
IV. Assays  
Concentrations of progesterone [levels] in vena caval samples were assayed using 
Coat-A-Count kit® purchased from (Diagnostic Products Corporation, Los Angeles, CA).  
Procedures outlined by the manufacturer (100 uL of sample/tube); were followed and 
concentrations of progesterone were read using WALLAC 1470 WIZARD Automatic 
Gamma Counter® (Wallac Inc., Gaithersburg, MD).  The progesterone assay’s sensitivity 
was 0.29 ng/mL and the intra-assay coefficient of variation for the quality controls 
averaged 7.5% (Table 1).  Figure 1 shows that concentrations of progesterone did not 
differ with catheter lengths of 48 to 52 cm, so catheters were placed at 50 cm.   
The cytokine, TNF-α, also known as cachectin, is secreted by macrophages in 
response to various pathogens.  TNF-α was assayed in both the jugular samples and the 
[vena caval] samples in single assays at the USDA in Beltsville, Maryland under the 
supervision of Dr. Ted Elsasser in the Growth Biology Laboratory, following, the 
protocol of Kenison et al. (1990) non-equilibrium assay.  The intra-assay coefficient of 
variation for the quality controls is represented in Table 1.   
Serum amyloid protein A (SAA) is a putative serum precursor of the amyloid A 
protein.  It is well documented that SAA is a biomarker for infection (Nakayama T. et al., 
1993).  A multispecies SAA solid phase ELISA kit was purchased from Biosource 
International, Inc., Camarillo, CA.  Outlined procedures from Biosource International, 
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Inc. were followed accordingly except that samples were diluted 1:8000, instead of 1:500 
as recommended by manufacturer; based on assays; ELISA plates were read using 
SPECTRAmax®  PLUS384 (Molecular Devices Corporation, Sunnyvale CA).  The data 
were transformed by subtracting all values at time points 15 minutes through 2 hours 
from baseline and then by multiplying each value by 100 to express the data as percent 
change from baseline.     
Table 1 Assay Coefficients of Variation 
Variable Measured Item CV% 
Progesterone OVX 16.22 
 OVX-S 6.15 
 SB 3.47 
 SS 4.42 
 LC 7.20 
  Average= 7.49 
TNF- α BO (Jugular) 1.075 
 BO(Vena Caval) 0.2196 
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Figure 1 Day 4 of Gestation Progesterone Profiles of Vena Caval Catheters 
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VII. Statistics  
The primary experimental null hypothesis was: 
1. Peptidoglycan-polysaccharide intoxications do not result in a difference of 
concentrations in TNF-α between the jugular and vena cava. 
 The secondary experimental null hypothesis was: 
2. Concentrations of Serum Amyloid A are not different between control and treated 
ewes.   
The results were analyzed using repeated measures analysis of variance SAS GLM 
procedure (1999, SAS Institute, Carry, NC).  Significance level was 0.05.  
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Results 
 
I. TNF-α concentrations in Suffolk Ewes: 
 
Treatment of Suffolk ewes with 30ug/kg BW PG-PS complex (PG-PS, n=6) 
increased (p = 0.0021) production of TNF-α measured in the vena cava compared to 
control ewes (Figure 2, n = 4).  However, concentration of TNF-α production in the 
jugular vein after PG-PS intoxication was not significantly different (p > 0.05) in treated 
compared to control ewes.  Concentrations of TNF-α from treated and control ewes did 
not differ with site of sampling [p > 0.05, Figure 3, n = 4]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Vena Caval Concentrations of TNF-α 
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Figure 3 Jugular Concentrations of TNF-α 
 
 
 
 
 
 
 
 
II.  Serum Amyloid A concentrations in Suffolk Ewes: 
 
 Treatment of Suffolk ewes with PG-PS did not affect concentrations of serum 
amyloid A (p > 0.05).   
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Figure 4 Jugular Concentrations of Serum Amyloid A 
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Discussion  
The 30 ug/kg BW PG-PS (medium dosage, Stewart et al. 2003) was sufficient to 
elicit a local immune response as quantified by increased concentrations of TNF-α in the 
[caudal vena cava] of treated ewes, but not enough to increase TNF-α in the jugular vein 
above controls, representing systemic circulation in treated ewes.  Stewart et al. (2003) 
showed that a 30 ug/kg BW dosage of PG-PS did not result in lowered pregnancy rates.  
Thus in the current study it can be said that, a 30 ug/kg BW PG-PS challenge was enough 
to illicit the production of TNF-α in proximity to the reproductive tract, but in accordance 
with Stewart et al. (2003), the dosage was not high enough to meet the threshold for 
embryonic toxicity, or to cause sepsis.  Stewart et al. (2003) were among the first to 
observe that upon a PG-PS challenge in early pregnant ewes (day 5), prostaglandin 
(PGF2-α) as measured by its metabolite, PGFM, subsequently increased in a dose-
dependant manner, and that progesterone declined in all treated ewes.  However, Stewart 
et al. (2003) observed that pregnancy rates declined only in ewes treated with high 
dosages of PG-PS, in which PGFM was high, but that pregnancy rates were maintained in 
medium and low dosages of PG-PS in which PGFM was lower, arguing for another 
synergistic factor in the equation for embryonic loss.  Costine et al. (2001) showed that 
exogenous PGF2-α, and the regressing CL could be embryotoxic on days 4-7 after 
mating in progestagen-supplemented ewes.  Holaskova et al. (2004) showed that 
immunization to PG-PS did not prevent pregnancy loss even though IgG anti-PG-PS 
titers were high.  Therefore it was suggested that the innate immune system may have a 
more important role during early embryonic loss.  As cited by Stewart et al. (2003), in 
vitro culture of preimplantation mouse embryos with TNF-α prevented embryos from 
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reaching the blastocyst stage and decreased total cell number.  Stewart et al. (2003) stated 
that increases in inflammatory cytokines, such as TNF-α, could potentially have direct 
effects on embryonic survival after PG-PS treatment.  Therefore the local production of 
TNF-α from the reproductive tract and in proximity to the reproductive tract would be 
considered important characteristics of the PG-PS intoxicated animal.   
    To further delineate what physiological impacts that resulted from the single 30 
ug/kg BW PG-PS intoxication, SAA was measured.  Serum amyloid A, as discussed in 
the literature review, is an acute phase protein.  Plasma SAA can be increased up to 1000-
fold of the basal level in inflammatory disorders in human and other species, suggesting 
that it is an important indicator of disease status as cited in Sadaki K. et al. (2003).  In the 
present study, concentrations of SAA were not significantly different in the PG-PS 
treated ewes from the controls.  However no strong conclusions can be made about the 
current observation of SAA for the following reasons: 
1) Species variability; a multispecies SAA solid phase ELISA kit was 
purchased from Biosource Inc., Camerillo, CA validated for bovine, 
porcine, canine, human, and equine.  The purchased SAA assay kit was 
not validated for sheep.  However, based on the premise of a high 
degree of conservation of the SAA genes and proteins that have been 
maintained through evolution of eutherian animals, SAA and other 
acute-phase proteins are likely to have important biological actions 
similarly seen in multiple species; (Sasaki K. et al. 2003) and should 
not be variable.   
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2) Sampling; as previously mentioned serum amyloid A (SAA) is 
produced after initiation of the acute phase response to inflammation.  
Cytokines such as IL-1, IL-2 and TNF- α induce acute-phase protein 
production and secretion from liver hepatocytes.  Thus, there is an 
important lag time to consider when sampling the intoxicated animal. 
This was not considered in the current study; therefore blood sampling 
could be taken at later times to improve the likelihood of observing 
significant differences in treated vs. control ewes.   
3) Concentrations of SAA and accessory proteins in sheep plasma; in 
a preliminary assay it was determined that sheep plasma samples were 
too concentrated with SAA as compared to standards. A 1:8000 
dilution was determined optimum; however when samples were run 
again, neither control or treated blood samples started at the same 
baseline.  There is a potential that an accessory protein is interfering 
with the assay for SAA in treated ewes.  Perhaps further dilution and 
validation would have been appropriate.   
It is well known that during early pregnancy immune cellular infiltration of 
decidual tissue is up-regulated.  An “inflammatory” response to semen occurs on the day 
of mating and is characterized by massive inflammatory leukocyte infiltration and 
heightened cytokine gene expression in the uterus as cited by Dalton et al. (1994). This 
depicts an ironic situation wherein after opsonizing bacterial pathogens are introduced to 
the reproductive tract of the dam at mating, the immune system switches its focus to 
downplay its defense mechanisms for the duration of early pregnancy until maternal 
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recognition, implantation, and establishment of pregnancy occur.  No doubt progesterone 
plays a large role in the “switch” of the immune system; progesterone has been described 
as an immuno-inhibitory hormone whose actions down-regulate proinflammatory 
immune activities.  It has been documented by Seals et al. (2002) that progesterone 
treatments administered twice daily to both ovariectomized and intact postpartum ewes 
before intrauterine inoculation with bacteria resulted in suppressed uterine immunity 
therefore leaving the uterus susceptible to bacterial induced infections.  Seals et al. (2002) 
suggested that the uterine immune system is up-regulated postpartum until it is exposed 
to progesterone which allows the uterine immune system to become down-regulated and 
susceptible to infections.  In the current study, catheter placement in the vena cava 
showed concentrations of progesterone appropriate for day-5 pregnant ewes.  During 
early pregnancy concentrations of progesterone are derived from the (CL), until the 
placenta takes over, around day 50, in ewes production of progesterone needed for 
maintenance of pregnancy.   The CL itself is a transient endocrine organ that produces 
progesterone needed to keep the uterine endometrium rich with glandular secretions ideal 
for attachment/implantation of the embryo. The maintenance of the CL is critical, and can 
be susceptible to various insults, most specifically those induced after inflammation i.e. 
PGF2-α, acute phase proteins and TNF-α production.  
  LPS challenges have been shown to activate macrophages along with NK cells, 
which work in synergy to produce large amounts of TNF-α local to the embryo during 
early pregnancy in CBA/J X DBA/2 mice (Duclos et al., 1995; Chaouat et al., 1990; 
Gendron et al., 1990; Baines et al., 1996, 1997).  Further, LPS-induced embryonic death 
results from maternal and not fetal factors as shown in LPS-hyporesponsive murine strain 
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C3H/HeJ (Silver et al., 1994).  The current research observations show local, maternal (in 
proximity to reproductive tract) TNF-α production in response to PG-PS treatment during 
this time (day 5) of early pregnancy in ewes.  Attempts to further classify the mechanisms 
of a PG-PS intoxication by measuring SAA profiles were not successful in this current 
study, however further research is needed to characterize the innate immune systems 
effects early embryonic loss in all species induced by PG-PS intoxication and infection.   
It is important not to over look, whether in cattle or sheep, that proper 
management techniques will help curb mastitis and the associated embryonic loss in high 
yielding dairy animals.  Pyorala (2002) states that the best progress in the control of 
mastitis, short term, can be made by improving the nutrition, environment and 
management of dairy animals.  However, in the long term, it will be critical for scientists 
to understand the host’s innate and adaptive defense mechanisms associated with each 
individual pathogen of mastitis and its links to embryonic loss before clinical 
applications, promised by biotechnologies, will be of use to the producer.   
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